SWIB's investment management of the WRS generated more than $3.1 billion of net outperformance over the last five years. In 2023, SWIB beat its one-, five-, and ten-year benchmarks for the Core Trust Fund.
This report presents the results of the annual actuarial valuation of benefit liabilities and costs of the Accumulated Sick Leave Conversion Credit (ASLCC) Programs as of December 31, 2012.
Report
Active Employee /
Retiree /
Board Member /
State Employer
This report presents the results of the annual actuarial valuation of benefit liabilities and costs of the Accumulated Sick Leave Conversion Credit (ASLCC) Programs as of December 31, 2011.
Report
Active Employee /
Retiree /
Board Member /
State Employer
This report presents the results of the annual actuarial valuation of benefit liabilities and costs of the Accumulated Sick Leave Conversion Credit (ASLCC) Programs as of December 31, 2007.
Report
Active Employee /
Retiree /
Board Member /
State Employer
This report presents the results of the annual actuarial valuation of benefit liabilities and costs of the Accumulated Sick Leave Conversion Credit (ASLCC) Programs as of December 31, 2006.
Report
Active Employee /
Retiree /
Board Member /
State Employer
This report presents the results of the annual actuarial valuation of benefit liabilities and costs of the Accumulated Sick Leave Conversion Credit (ASLCC) Programs as of December 31, 2005.
Report
Active Employee /
Retiree /
Board Member /
State Employer
This report presents the results of the annual actuarial valuation of benefit liabilities and costs of the Accumulated Sick Leave Conversion Credit (ASLCC) Programs as of December 31, 2004.
